Participate in Research

Browse Clinical Trials
New Device Trial for Patients of GVI with Brain Aneurysms
Protocol: STUDY00006638
Full Title
Flow Re-Direction Endoluminal Device X (FRED??? X???) Post-Approval Study (Fred X PAS Study)
Description
The University at Buffalo (UB) Department of Neurosurgery is enrolling patients of Gates Vascular Institute (GVI) that have been diagnosed with a brain aneurysm for a new clinical trial. The goal of the study is to learn more about the safety and effectiveness of a new device (the FRED X device) in treating people with brain aneurysms.

Participants will be enrolled in the study for 5 years. Following the surgery to implant the study device, they will complete follow-up visits at 30 days, 6-months, 12-months, 2-years, 3-years, and 5-years. Throughout the study, participants will complete physical exams, lab tests, and surveys.
Compensation: No
Eligibility
Adults 22 to 75 years old Have been diagnosed with an aneurysm in a brain artery Not currently pregnant
Age Group: Adults
Principal Investigator: ADNAN SIDDIQUI
ClinicalTrials.gov: Open Study
Contact(s)
JENNIFER GAY
jgay@ubns.com
+1 716-888-4811
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login